RT Journal Article SR Electronic T1 Resolution of Refractory Symptoms of Secondary Erythermalgia With Intermittent Epidural Bupivacaine JF Regional Anesthesia & Pain Medicine JO Reg Anesth Pain Med FD BMJ Publishing Group Ltd SP 488 OP 490 DO 10.1053/rapm.2001.25930 VO 26 IS 5 A1 Lori J. Stricker A1 Carmen R. Green YR 2001 UL http://rapm.bmj.com/content/26/5/488.abstract AB Background and Objectives Erythermalgia is a rare disorder characterized by erythema, edema, elevated skin temperature, and burning pain of the hands and/or feet. The etiology of primary erythermalgia is idiopathic while secondary erythermalgia is associated with autoimmune and rheumatologic factors. Symptoms are typically refractory to medical management. We report the use of epidural bupivacaine as a treatment option for secondary erythermalgia.Case Report A 28-year-old woman presented with secondary erythromelalgia that was characterized by severe pain, swelling, and erythema. Medical management failed and a lumbar epidural dosed with bupivacaine was used. This resulted in complete resolution of the patient's symptoms.Conclusion Intermittent epidural bupivacaine may provide treatment of the refractory symptoms of secondary erythermalgia.